Loading: 100%
Zoetis logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Florham Park, United States of AmericaFlorham Park, United States of Americano data available
Employees 9,000 (as per Q1 2017)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker ZTSno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 174048566472
datesClosing price (adj.)
13.10.201765.44
11.10.201764.28
04.10.201763.57
27.09.201763.21
20.09.201764.48
13.09.201765.28
06.09.201763.39
30.08.201761.94
23.08.201761.36
16.08.201761.50
09.08.201760.81
02.08.201761.54
26.07.201762.06
19.07.201762.42
12.07.201762.56
05.07.201762.55
27.06.201762.76
20.06.201763.00
13.06.201761.96
06.06.201762.87
30.05.201762.15
23.05.201761.33
16.05.201760.23
09.05.201759.33
02.05.201756.37
25.04.201755.02
18.04.201753.46
11.04.201752.76
04.04.201752.56
28.03.201753.96
21.03.201753.19
14.03.201753.22
07.03.201752.87
28.02.201753.11
21.02.201753.27
14.02.201754.82
07.02.201755.77
31.01.201754.74
24.01.201753.58
17.01.201752.92
10.01.201753.63
03.01.201753.29
27.12.201653.42
19.12.201652.09
12.12.201650.63
05.12.201649.54
28.11.201649.87
21.11.201649.72
14.11.201648.68
07.11.201649.70
31.10.201647.44
24.10.201650.64
17.10.201649.65
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
65.44n/a
Market Capitalisation
in million USD
32,118n/a
Enterprise Value
in million USD
35,871n/a
Common Shares Outstanding
as per Apr 28, 2017
490,796,861n/a
Preferred Shares Outstanding
as per Apr 28, 2017
n/a
Average Basic Shares Outstanding
TTM
494,465,000n/a
Average Diluted Shares Outstanding
TTM
497,175,000n/a
Index Membership
n/a
Business Summary
Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other related products.
no data available
Key Financials & Ratios (all figures TTM as per Dec 31, 2016, million USD, full statements further below)
Profit & Loss
Revenues 4,888n/a
Gross Profit 3,222n/a
Operating Income 1,397n/a
EBITDA 1,637n/a
Net Profit 821n/a
Balance Sheet
Cash and Cash Equivalents 727n/a
Receivables 913n/a
Total Current Assets 3,390n/a
PP&E 1,381n/a
Total Assets 7,649n/a
Accounts Payable 265n/a
Current Debt 0n/a
Total Current Liabilities 1,117n/a
Long-Term Debt 4,468n/a
Total Liabilities 6,150n/a
Total Equity 1,499n/a
Cash Flow
Depreciation & Amortisation 240n/a
Change in Working Capital -439n/a
Operating Cash Flow 713n/a
Net Change in PP&E and Intangibles -126n/a
Investing Cash Flow -214n/a
Dividends Paid -188n/a
Financing Cash Flow -903n/a
Total Change in Cash -427n/a
Free Cash Flow 663n/a
Profitability Ratios
Gross Margin 65.9%n/a
Operating Margin 28.6%n/a
Net Profit Margin 16.8%n/a
Return on Equity 54.6%n/a
Return on Assets 10.7%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 21.91n/a
EV/Sales 7.34n/a
Book to Market Value 0.05n/a
Other Ratios
Current Ratio 303.5%n/a
Liabilities to Equity Ratio 410.3%n/a
Debt to Assets Ratio 58.4%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
4,233
4,336
4,561
4,785
4,765
4,888
Sales & Services Revenue
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
Cost of revenue
-1,652
-1,563
-1,669
-1,717
-1,738
-1,666
Cost of Goods & Services
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
Gross Profit
2,581
2,773
2,892
3,068
3,027
3,222
Other Operating Income
0
0
0
0
0
0
Operating Expenses
-1,949
-1,943
-2,072
-2,099
-1,957
-1,825
Selling, General & Administrative
-1,453
-1,470
-1,613
-1,643
-1,532
-1,364
Selling & Marketing
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
Research & Development
-427
-409
-399
-396
-364
-376
Depreciation & Amortization
-69
-64
-60
-60
-61
-85
Provision For Doubtful Accounts
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
Operating Income (Loss)
632
830
820
969
1,070
1,397
Non-Operating Income (Loss)
-84
15
-104
-124
-205
-164
Interest Expense, net
-36
-31
-113
-117
-124
-166
Interest Expense
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-48
46
9
-7
-81
2
Pretax Income (Loss), Adjusted
548
845
716
845
865
1,233
Abnormal Gains (Losses)
-154
-135
-26
-25
-320
-5
Acquired In-Process R&D
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
Pretax Income (Loss)
394
710
690
820
545
1,228
Income Tax (Expense) Benefit, net
-146
-274
-187
-233
-206
-409
Current Income Tax
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
Income (Loss) from Continuing Operations
248
436
503
587
339
819
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
Income (Loss) Including Minority Interest
248
436
503
587
339
819
Minority Interest
-3
0
1
-4
0
2
Net Income
245
436
504
583
339
821
Preferred Dividends
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Net Income Available to Common Shareholders
245
436
504
583
339
821
Remarks
restated on Mar 26, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 24, 2016 n/a
calculated values,
restated on Feb 16, 2017 n/a
calculated values,
restated on Feb 16, 2017 n/a
calculated values,
restated on Feb 16, 2017 n/a
calculated values,
Balance SheetBS data quality: 97% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
317
610
882
1,154
727
Cash & Cash Equivalents
n/a
317
610
882
1,154
727
Short Term Investments
n/a
0
0
0
0
0
Accounts & Notes Receivable
n/a
900
1,138
980
937
913
Accounts Receivable, Net
n/a
900
1,138
980
937
913
Notes Receivable, Net
n/a
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
Inventories
n/a
1,345
1,293
1,289
1,467
1,502
Raw Materials
n/a
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
Other Short Term Assets
n/a
302
316
314
272
248
Prepaid Expenses
n/a
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
71
0
Deferred Tax Assets
n/a
101
97
109
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
201
219
205
201
248
Total Current Assets
n/a
2,864
3,357
3,465
3,830
3,390
Property, Plant & Equipment, Net
n/a
1,241
1,295
1,318
1,307
1,381
Property, Plant & Equipment
n/a
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
Other Long Term Assets
n/a
2,157
1,906
1,805
2,776
2,878
Intangible Assets
n/a
868
803
727
1,190
1,228
Goodwill
n/a
985
982
976
1,455
1,481
Other Intangible Assets
n/a
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
Deferred Tax Assets
n/a
216
63
54
82
96
Derivative & Hedging Assets
n/a
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
88
58
48
49
73
Total Noncurrent Assets
n/a
3,398
3,201
3,123
4,083
4,259
Total Assets
n/a
6,262
6,558
6,588
7,913
7,649
Liabilities and owners' equity
Payables & Accruals
n/a
543 543000000
1,381 1381000000
1,071 1071000000
1,313 1313000000
1,076 1076000000
Accounts Payable
n/a
319 319000000
506 506000000
290 290000000
293 293000000
265 265000000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
36 36000000
42 42000000
47 47000000
52 52000000
Other Payables & Accruals
n/a
224 224000000
839 839000000
739 739000000
973 973000000
759 759000000
Short Term Debt
n/a
73 73000000
15 15000000
7 7000000
405 405000000
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
507 507000000
19 19000000
8 8000000
63 63000000
41 41000000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
507 507000000
19 19000000
8 8000000
63 63000000
41 41000000
Total Current Liabilities
n/a
1,123 1123000000
1,415 1415000000
1,086 1086000000
1,781 1781000000
1,117 1117000000
Long Term Debt
n/a
509 509000000
3,642 3642000000
3,624 3624000000
4,463 4463000000
4,468 4468000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
4,772 4772000000
539 539000000
541 541000000
578 578000000
565 565000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
323 323000000
322 322000000
277 277000000
264 264000000
244 244000000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
4,449 4449000000
217 217000000
264 264000000
314 314000000
321 321000000
Total Noncurrent Liabilities
n/a
5,281 5281000000
4,181 4181000000
4,165 4165000000
5,041 5041000000
5,033 5033000000
Total Liabilities
n/a
6,404 6404000000
5,596 5596000000
5,251 5251000000
6,822 6822000000
6,150 6150000000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
0 0
883 883000000
963 963000000
1,017 1017000000
1,029 1029000000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
-203 -203000000
-421 -421000000
Retained Earnings
n/a
0 0
276 276000000
709 709000000
876 876000000
1,477 1477000000
Other Equity
n/a
-157 -157000000
-219 -219000000
-361 -361000000
-622 -622000000
-598 -598000000
Equity Before Minority Interest
n/a
-157 -157000000
940 940000000
1,311 1311000000
1,068 1068000000
1,487 1487000000
Minority Interest
n/a
15 15000000
22 22000000
26 26000000
23 23000000
12 12000000
Total Equity
n/a
-142 -142000000
962 962000000
1,337 1337000000
1,091 1091000000
1,499 1499000000
Total Liabilities & Equity
n/a
6,262 6262000000
6,558 6558000000
6,588 6588000000
7,913 7913000000
7,649 7649000000
Remarks restated on n/a restated on Mar 26, 2014 n/a restated on Feb 27, 2015 n/a restated on Feb 24, 2016 n/a restated on Feb 16, 2017 n/a restated on May 4, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
248
436
503
587
339
819
Net Income
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Depreciation & Amortization
205
200
209
204
199
240
Non-Cash Items
161
-33
94
84
334
93
Stock-Based Compensation
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
Change in Working Capital
-117
-149
-125
-249
-208
-439
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
Cash from Operating Activities
497
454
681
626
664
713
Change in Fixed Assets & Intangibles
-101
-123
-175
-186
-222
-126
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-345
0
0
0
-883
-88
Net Cash from Divestitures
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
Other Investing Activities
-3
-12
-4
-1
-10
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
Cash from Investing Activities
-449
-135
-179
-187
-1,115
-214
Dividends Paid
-416
-63
-98
-146
-168
-188
Cash From (Repayment of) Debt
-143
0
2,641
-8
1,115
-405
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
0
-203
-300
Increase in Capital Stock
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
Other Financing Activities
529
-15
-2,743
0
11
-10
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
Cash from Financing Activities
-30
-78
-200
-154
755
-903
Net Cash Before Disc. Operations and FX
18
241
302
285
304
-404
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
Net Cash Before FX
18
241
302
285
304
-404
Effect of Foreign Exchange Rates
-2
-3
-9
-13
-32
-23
Net Changes in Cash
16
238
293
272
272
-427
Remarks
restated on Mar 26, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 24, 2016 n/a
calculated values,
restated on Feb 16, 2017 n/a
calculated values,
restated on Feb 16, 2017 n/a
calculated values,
restated on Feb 16, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo